J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):34-38.e1. doi: 10.1016/j.japh.2023.10.017. Epub 2023 Oct 21.
As the U.S. population becomes more racially and ethnically diverse, it is increasingly important to characterize health inequities for targeted intervention. As it stands, demographic data regarding race and ethnicity for patients and pharmacy trainees alike are aggregated into heterogenous population groups, resulting in findings that may inaccurately reflect the experiences of smaller subgroups. Disaggregation of patient outcomes data can serve to better inform public health interventions for the most vulnerable populations. In pharmacy, disaggregation can allow for better identification of racial and ethnic subgroups who have been traditionally excluded from funding support among other opportunities. In this commentary, we provide historical context and actionable recommendations to better describe our patient and pharmacy trainee populations, with the objectives of improving pharmacist representation and health equity.
随着美国人口的种族和民族构成变得更加多样化,为有针对性地干预而描述健康不平等现象变得越来越重要。目前,有关患者和药剂师培训生的种族和民族的人口统计数据被汇总到异质人群组中,导致的研究结果可能不准确地反映较小亚组的经验。对患者结果数据进行细分可以更好地为最弱势群体的公共卫生干预措施提供信息。在药学领域,细分可以更好地识别传统上被排除在资金支持之外的种族和少数民族亚组等机会。在这篇评论中,我们提供了历史背景和可行的建议,以更好地描述我们的患者和药剂师培训生群体,目的是提高药剂师的代表性和健康公平性。